In recent trading session, ZyVersa Therapeutics Inc (NASDAQ:ZVSA) saw 1.72 million shares changing hands at last check today with its beta currently measuring 0.64. Company’s recent per share price level of $2.07 trading at -$0.19 or -8.21% at last check today assigns it a market valuation of $2.22M. That most recent trading price of ZVSA’s stock is at a discount of -2169.08% from its 52-week high price of $46.97 and is indicating a discount of -0.48% from its 52-week low price of $2.08. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 26380.0 shares which gives us an average trading volume of 79.95K if we extend that period to 3-months.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information
Upright in the red during last session for losing -8.21%, in the last five days ZVSA remained trading in the red while hitting it’s week-highest on Tuesday, 10/15/24 when the stock touched $2.07 price level, adding 13.03% to its value on the day. ZyVersa Therapeutics Inc’s shares saw a change of -76.95% in year-to-date performance and have moved -11.72% in past 5-day. ZyVersa Therapeutics Inc (NASDAQ:ZVSA) showed a performance of -14.63% in past 30-days. Number of shares sold short was 23829.0 shares which calculate 0.32 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ZyVersa Therapeutics Inc (ZVSA) estimates and forecasts
Statistics highlight that ZyVersa Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -66.86% of value to its shares in past 6 months, showing an annual growth rate of 97.65% while that of industry is 17.50. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders
Insiders are in possession of 0.61% of company’s total shares while institution are holding 5.18 percent of that, with stock having share float percentage of 5.21%. Investors also watch the number of corporate investors in a company very closely, which is 5.18% institutions for ZyVersa Therapeutics Inc that are currently holding shares of the company.
